In gratitude of the loyal support of our members, the CNS is offering complimentary 2021 Annual Meeting registration to all members! Learn more.

  • Prognostic implication of size on outcomes of Pituitary Macroadenoma: a comparative analysis of Giant Adenoma with Non-giant Macroadenoma

    Final Number:
    4055

    Authors:
    Fauzan Alam Hashmi MBBS; Syed Ather Enam; Muhammad Bilal Tariq; Asra Tanwir

    Study Design:
    Other

    Subject Category:

    Meeting: Congress of Neurological Surgeons 2018 Annual Meeting - Late Breaking Science

    Introduction: The authors aimed to differentiate giant pituitary adenomas from non-giant pituitary macroadenomas, distinguishing them based on the presenting complain, surgical procedures, tumor resections and recurrence.

    Methods: A retrospective analysis of pituitary macroadenomas that underwent surgical resection at Aga Khan University, Pakistan was done. Tumors were divided into two groups for comparison, tumors greater than 4 cm were classified as giant pituitary adenoma while macroadenomas smaller than 4 cm were termed as non-giant pituitary macroadenoma. Between 2006 and 2017, 75 patients had resection of giant pituitary adenoma. To match these cases, 75 patients with non-giant macroadenoma were chosen using non-probability sampling

    Results: The most common complaint of patients with non-giant pituitary macroadenoma were visual deterioration, reported by 77.3% of patients with non-giant pituitary macroadenoma and 89.3% with giant pituitary adenoma. The mean volume of the non-giant adenomas was 6.3ml (range 0.45ml-22ml) in contrast to giant pituitary adenomas with a mean volume of 30.1 ml (range 10.8 ml-149.4) (p=0.001). Microscopic transsphenoidal approach was the most commonly used procedure in both non-giant macroadenoma (49%) and GPA (44.8%). Tumor recurrence/progression was seen in 9.3% of patients with non-giant pituitary macroadenoma and 44% of patients with giant pituitary adenoma p=<0.001. The mean extent of resection was 88.9% for non-giant macroadenomas whereas the mean extent of resection was 76.7% for giant pituitary adenomas (p=0.03).

    Conclusions: When compared with non-giant macroadenoma, giant pituitary adenomas are more likely to present with a higher number of preoperative symptoms, lesser chances of tumor resection and postoperative symptoms. They are also associated with higher number of recurrence.

    Patient Care: Giant pituitary adenoma patients should be counselled before hand for a difficult course, surgeons should also be aware of the invasiveness of the tumor.

    Learning Objectives: Comparison of Giant Pituitary adenomas vs non-giant macroadenomas.

    References:

We use cookies to improve the performance of our site, to analyze the traffic to our site, and to personalize your experience of the site. You can control cookies through your browser settings. Please find more information on the cookies used on our site. Privacy Policy